May 11, 2017 / 11:22 AM / 3 months ago

BRIEF-Recro Pharma reports Q1 loss per share of $0.42

May 11 (Reuters) - Recro Pharma Inc

* Recro Pharma reports first quarter 2017 financial results

* Q1 loss per share $0.42

* Sees FY 2017 revenue $55 million to $60 million

* Q1 revenue $18.7 million versus I/B/E/S view $15.2 million

* Q1 earnings per share view $-0.58 -- Thomson Reuters I/B/E/S

* On track to file NDA with U.S. FDA for IV Meloxicam during early Q3 2017

* Reiterates its expectation that it will generate revenue in range of $55-$60 million in 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below